Risk Factors of Jaw Osteoradionecrosis in Oral Cavity Cancer Patients Post-Radiotherapy (AOITC)
Risk Factors of Jaw Osteoradionecrosis in Oral Cavity Cancer Patients Post-Radiotherapy: A Multi-center Retrospective Cohort Study
Osteoradionecrosis (ORN) of the jaw is a serious complication that can occur after radiation therapy for head and neck cancers, including oral cavity cancer (OCC). ORN happens when jawbone tissue dies and fails to heal, often triggered by dental issues like tooth extractions or poorly fitting dentures. Symptoms can include exposed bone, pain, difficulty opening the mouth, trouble swallowing, and even jaw fractures-leading to major physical and emotional challenges.
The likelihood of ORN varies widely, from less than 1% to over 50% in head and neck cancer patients. For OCC specifically, studies report rates from 4% up to 25%. Treatment depends on how much bone is affected and can range from medication to major surgery.
Risk factors include radiation dose, tumor location, oral health, dental extractions, lifestyle habits (like alcohol use), and other health conditions. Poor oral hygiene, high radiation doses, and alcohol use are among the most common risks. However, current data on OCC patients is limited and often not broadly applicable.
This study will retrospectively examine what increases the risk of ORN in OCC patients who received radiation therapy before or after surgery. Using data from multiple international centers, it aims to identify patterns and provide globally relevant insights. The results will help guide prevention strategies and create evidence-based guidelines to reduce ORN and improve long-term outcomes for these patients.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Benjamin Bretzinger
- Numero di telefono: +41 81 414 21 11
- Email: benjamin.bretzinger@aofoundation.org
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Patients will be selected from the primary care center where the patients received their initial treatment and followed up for at least 24months
Descrizione
Inclusion Criteria:
- Adults (≥18 years) diagnosed with OCC and treated with radiotherapy with curative intent (preoperative or/and postoperative, not palliative; definitive RT)
- Patients who completed the full prescribed radiotherapy course; patients remain eligible if radiotherapy was discontinued due to suspected and subsequently confirmed ORN
- Available, complete medical records including RT details, oral status, comorbidities, dental procedure details (as applicable), and lifestyle factors (as applicable)
- Documented informed consent from the treated patient, where applicable, permitting the use of their medical records for research purposes, in accordance with the requirements of the Institutional Review Board (IRB) or Ethics Committee (EC).
- Availability of at least 24 months of follow-up data after completion of radiotherapy, or follow-up until the occurrence of ORN, death, or loss to follow-up, whichever occurs first.
- Completion of the radiotherapy course on or before 31 December 2024.
Exclusion Criteria:
- Patients with non-oral cavity primary cancers (eg, oropharynx, larynx)
- Patients treated only with surgery or conservatively, without any form of RT
- Incomplete or missing medical records
- Record of use of antiresorptive (eg, bisphosphonate, denosumab) and antiangiogenic drugs
- Patients with jaw necrosis attributable to non-radiation-related causes, such as medication-related osteonecrosis of the jaw (MRONJ), trauma, or odontogenic infections
- Patients with known metastatic bone disease in the jaw
- Patients who discontinued radiotherapy for reasons unrelated to ORN suspicion or confirmation (eg, death, dropout, treatment intolerance, or other non-ORN related causes)
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Modelli osservazionali: COHORT
- Prospettive temporali: RETROSPECTIVE
Numero di gruppi/coorti
Coorti e interventi
Gruppo / CoorteGruppo / Coorte |
|---|
|
Cases (ORN group)
Developed clinically and radiographically or histologically confirmed osteoradionecrosis (ORN) of the jaw following radiotherapy. |
|
Control (non-ORN group)
No clinical, radiological, or histological diagnosis of ORN during the follow-up period. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Development of osteoradionecrosis (ORN) of the jaw
Lasso di tempo: After completion of pre-and/or postoperative radiotherapy up to 24 months
|
The primary outcome is the development occurrence (yes/no) of ORN after completion of pre- and/or postoperative RT. The objective is to identify and evaluate patient-, tumor-, treatment-, and region-related risk factors associated with the development of ORN across multiple geographic regions. Scoring Scale: The primary endpoint will be treated as a binary variable: 0 = No ORN 1 = Development of ORN Time to ORN onset (interval between completion of RT and clinical diagnosis of ORN) will also be recorded for time-to-event analyses. |
After completion of pre-and/or postoperative radiotherapy up to 24 months
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Incidence of ORN Across Geographic Regions
Lasso di tempo: After completion of pre-and/or postoperative radiotherapy up to 24 months
|
To compare the incidence rates across geographical regions, namely between the Eastern and Western world, and High-Income Countries versus Low and Middle-Income Countries. |
After completion of pre-and/or postoperative radiotherapy up to 24 months
|
|
Severity of ORN by Tumor Characteristic
Lasso di tempo: After completion of pre-and/or postoperative radiotherapy up to 24 months
|
To evaluate the variability in the severity of osteoradionecrosis (ORN) based on primary tumor site (eg, tongue, floor of mouth, oral tongue, buccal mucosa, gingiva), histological tumor type (eg, adenoid cystic carcinoma, squamous cell carcinoma), and tumor characteristics including size, clinical stage (T1-T4), overall stage (III-IVA), and nodal status (N0, N1-2B, N2C, N3 |
After completion of pre-and/or postoperative radiotherapy up to 24 months
|
|
Association between radiotherapy dose and ORN severity
Lasso di tempo: After completion of pre-and/or postoperative radiotherapy up to 24 months
|
To investigate the association between radiotherapy dose parameters (total dose and duration) and the severity grade of ORN among patients who develop ORN. Is there a correlation between increased radiation dose and duration and the severity of the condition? |
After completion of pre-and/or postoperative radiotherapy up to 24 months
|
|
Incidence and severity comparison of preop vs. postop RT
Lasso di tempo: After completion of pre-and/or postoperative radiotherapy up to 24 months
|
To compare the incidence and severity of ORN in patients undergoing preoperative versus postoperative radiotherapy |
After completion of pre-and/or postoperative radiotherapy up to 24 months
|
|
Incidence comparison across RT modalities
Lasso di tempo: After completion of pre-and/or postoperative radiotherapy up to 24 months
|
To compare the incidence ORN across different radiation modalities, including intensity-modulated radiotherapy (IMRT), volumetric modulated arc therapy (VMAT), and conventional three-dimensional conformal radiotherapy (3D-CRT) |
After completion of pre-and/or postoperative radiotherapy up to 24 months
|
|
To determine whether the mandible is more susceptible to ORN than the maxilla, or vice versa.
Lasso di tempo: After completion of pre-and/or postoperative radiotherapy up to 24 months
|
To determine whether the mandible is more susceptible to ORN than the maxilla, or vice versa. |
After completion of pre-and/or postoperative radiotherapy up to 24 months
|
|
Complication evaluation with pre- or postop RT
Lasso di tempo: After completion of pre-and/or postoperative radiotherapy up to 24 months
|
To evaluate potential complications associated with preoperative and postoperative radiotherapy |
After completion of pre-and/or postoperative radiotherapy up to 24 months
|
|
To analyze the influence of pre-radiotherapy dental extractions and oral hygiene status on the risk of developing ORN
Lasso di tempo: After completion of pre-and/or postoperative radiotherapy up to 24 months
|
To analyze the influence of pre-radiotherapy dental extractions and oral hygiene status on the risk of developing ORN |
After completion of pre-and/or postoperative radiotherapy up to 24 months
|
|
To examine the variability in ORN incidence and severity between patients who undergo dental extractions before versus after the completion of RT
Lasso di tempo: After completion of pre-and/or postoperative radiotherapy up to 24 months
|
To examine the variability in ORN incidence and severity between patients who undergo dental extractions before versus after the completion of RT |
After completion of pre-and/or postoperative radiotherapy up to 24 months
|
Collaboratori e investigatori
Sponsor
Sponsor
Investigatori
Investigatori
- Investigatore principale: Khalid Abdel-Galil, MD, Hamad Medical Corporation PO Box 3050 Doha, Qatar
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- ORN of the Jaw
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .